AIPT - Precision Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,411.655654.836456.495654.354
Cost of Revenue415.764148.045181.62303.982
Gross Profit995.891506.791274.875350.372
Operating Expenses
Research Development----
Selling General and Administrative8,857.276,560.3135,781.8864,750.015
Non Recurring----
Others----
Total Operating Expenses9,273.0346,708.3585,963.5065,053.997
Operating Income or Loss-7,861.379-6,053.522-5,507.011-4,399.643
Income from Continuing Operations
Total Other Income/Expenses Net-2,225.09850.505-1,019.003-390.887
Earnings Before Interest and Taxes-7,861.379-6,053.522-5,507.011-4,399.643
Interest Expense---0.003-390.887
Income Before Tax-10,086.477-6,003.017-6,526.014-4,790.53
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-10,086.477-6,003.017-6,526.014-4,790.53
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-10,086.477-6,003.017-6,526.014-4,790.53
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-10,086.477-6,003.017-6,526.014-4,790.53